Amarin Corporation plc (ADR) (NASDAQ:AMRN) is the 1st best-rated stock in this segment of the market. It is rated positively by 100% of the 9 brokerage analysts covering it.
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) is the 2nd best-rated stock in this segment of the market. It is rated positively by 100% of the 9 brokerage analysts covering it.
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is the 3rd best-rated stock in this segment of the market. It is rated positively by 100% of the 8 brokerage analysts covering it.
ArQule, Inc. (NASDAQ:ARQL) is the 4th best-rated stock in this segment of the market. It is rated positively by 100% of the 6 brokerage analysts covering it.
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is the 5th best-rated stock in this segment of the market. It is rated positively by 100% of the 6 brokerage analysts covering it.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is the 6th best-rated stock in this segment of the market. It is rated positively by 100% of the 6 brokerage analysts covering it.
AVI BioPharma, Inc. (NASDAQ:AVII) is the 7th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.
Medifast, Inc. (NYSE:MED) is the 8th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.
Nabi Biopharmaceuticals (NASDAQ:NABI) is the 9th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it.
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is the 10th best-rated stock in this segment of the market. It is rated positively by 100% of the 5 brokerage analysts covering it. For the latest updates PRESS CTR + D or visit Stock Market news Today
No comments:
Post a Comment